Bleeding update

Marco Pennazio1

  • 12nd Division of Gastroenterology, Department of Gastroenterology and Clinical Nutrition, S. Giovanni A.S. Hospital, Via Cavour 31-10123 Torino, Italy. mpen60@yahoo.com

Insights

Capsule endoscopy (CE) is the most efficient first-line diagnostic strategy for obscure bleeding. Proper patient selection and procedure timing maximize diagnostic yield and guide treatment decisions for obscure gastrointestinal bleeding (OGIB).

Area of Science:

  • Gastroenterology and Endoscopy
  • Medical Diagnostics

Background:

  • Obscure gastrointestinal bleeding (OGIB) presents a diagnostic challenge.
  • Capsule endoscopy (CE) is increasingly utilized for investigating OGIB.

Purpose of the Study:

  • To evaluate the diagnostic efficiency of capsule endoscopy (CE) as a first-line investigation for obscure bleeding.
  • To emphasize the importance of patient selection and procedural timing for maximizing diagnostic yield in CE.
  • To assess the impact of CE diagnosis on clinical decision-making and patient outcomes in OGIB.

Main Methods:

  • Review of existing literature and clinical practice guidelines regarding capsule endoscopy for obscure bleeding.
  • Analysis of factors influencing diagnostic yield, including patient selection and procedural timing.
  • Evaluation of the role of CE in guiding subsequent investigations and therapeutic strategies.

Main Results:

  • Capsule endoscopy (CE) is identified as the most efficient first-line diagnostic strategy for obscure bleeding.
  • High diagnostic yield is achievable with careful patient selection and appropriate procedural timing.
  • CE diagnosis positively influences clinical outcomes and decision-making for OGIB patients.

Conclusions:

  • Capsule endoscopy (CE) is a highly effective tool for diagnosing obscure gastrointestinal bleeding (OGIB) when used as a first-line approach.
  • Optimizing patient selection and procedure timing is crucial for maximizing the diagnostic value of CE.
  • Further large prospective trials are needed to determine the optimal therapeutic strategies for vascular lesions identified by CE in OGIB patients.

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...